Laurent Chardonnet
Keine laufenden Positionen mehr
Vermögen: 193 738 $ am 31.03.2024
Profil
Laurent Chardonnet served as Treasurer, Principal Accounting Officer & VP at Incyte Corp.
from 2004 to 2015.
Prior to that, he was Vice President-Finance at DrugAbuse Pharmaceutical, Inc. from 2000 to 2004.
He also worked as a Senior Consultant at PricewaterhouseCoopers LLP and as Chief Financial Officer, Controller & VP at Drugabuse Sciences, Inc. Mr. Chardonnet's most recent position was Chief Financial Officer & Senior Vice President at Axcella Health, Inc. from 2019 to 2021.
Currently, he is serving as the Chief Financial & Accounting Officer at Prelude Therapeutics, Inc. starting from 2021.
Mr. Chardonnet holds an MBA from Vanderbilt University and an undergraduate degree from Institut Supérieur de Gestion.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2024 | 40 873 ( 0,07% ) | 193 738 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Laurent Chardonnet
| Unternehmen | Position | Ende |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Director of Finance/CFO | 08.04.2024 |
| AXCA HEALPAR | Director of Finance/CFO | 28.11.2021 |
DrugAbuse Pharmaceutical, Inc.
 DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Director of Finance/CFO | 01.01.2004 |
| Drugabuse Sciences, Inc. | Director of Finance/CFO | - |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | - |
Ausbildung von Laurent Chardonnet
| Vanderbilt University | Masters Business Admin |
| Institut Supérieur de Gestion | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| AXCA HEALPAR | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
DrugAbuse Pharmaceutical, Inc.
DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
| Drugabuse Sciences, Inc. |
